Step change in care – changing the quality of life and supporting the NHS

Up to 500,000 GP appointments could be saved per annum with patient self-referral to audiology practices - easing pressure on the NHS, according to a new report.

Interacoustics introduces the game-changing Audible Contrast Threshold (ACT™) test

For more than a century, hearing aids have been prescribed based solely on the pure tone audiogram.With the introduction of ACT, Interacoustics goes beyond the audiogram, and is now able to address the number one complaint from people with hearing loss: hearing conversations in noisy situations.

A triple threat: showcasing Peptest at three ENT conferences

BIOHIT HealthCare is thrilled to be attending three prestigious otorhinolaryngology conferences over the next few weeks.

Interacoustics introduces a new diagnostic test at EUHA

Interacoustics is happy to introduce the Audible Contrast Threshold (ACT™) test; a new, diagnostic test to support the number one challenge with hearing loss: difficulty hearing speech in background noise.

MICRONOMIC® III Good things do come in small packages!

Entermed’s budget-friendly Micronomic III is a compact workstation designed to accommodate every ENT surgeons’ basic requirements in tight conditions.

Neuromod Devices’ €30m funding powers Lenire expansion

Neuromod Devices, the global technology business behind scientifically proven tinnitus treatment technology, Lenire, closed €30m funding to expand availability of the groundbreaking tinnitus intervention.

New Widex Study On Fractal Sound Stimulation in Hearing Aids Shows Positive Effects for Tinnitus Treatment and Overall Well-Being

Widex USA Inc. has published preliminary results of an ongoing study that validates the use of fractal sound stimulation, specifically new Widex SoundRelax tones, in treating tinnitus and supporting relaxation, concentration and well-being for all Widex wearers.

Peptest Q&A

Untreated reflux can cause inflammation, scarring, narrowing and precancerous changes in the oesophagus and larynx, and may increase the risk of asthma and sleep apnoea.

MED-EL revolutionises cochlear implantation with unparalleled synchrotron dataset of temporal bones

MED-EL, a leading innovator in the field of cochlear implant research and development, has announced an agreement with the Western University (London, Canada) and Mitacs to gain exclusive access to an extraordinary synchrotron dataset of temporal bones.

Grason-Stadler Releases GSI Cloud

Grason-Stadler, a worldwide leader of clinical audiometric systems, is pleased to announce the release of GSI Cloud™, a secure, cloud-based data management system.

Minimise waiting times with Peptest!

In laryngopharyngeal reflux (LPR), refluxed stomach contents travel up the oesophagus and reach the larynx, causing chronic extra-gastrointestinal symptoms such as a persistent cough, hoarseness or difficulty swallowing, meaning it is often attributed to ENT problems.

BIOHIT launches new quick test to help streamline gastroscopy referrals

BIOHIT HealthCare Ltd will be attending the upcoming BSG Live 2023 conference in Liverpool, where it will unveil a revolutionary new test to support decision making for gastroscopy referrals and improve the early detection of gastric cancer.